tiprankstipranks
QuidelOrtho down 9% to $42.90 after withdrawing submission for RVP4+ assay
PremiumThe FlyQuidelOrtho down 9% to $42.90 after withdrawing submission for RVP4+ assay
1M ago
QuidelOrtho withdraws FDA 510(k) submission for RVP4+ assay
PremiumThe Fly
QuidelOrtho withdraws FDA 510(k) submission for RVP4+ assay
1M ago
QuidelOrtho receives FDA 510k clearance for QuickVue  COVID-19 test
PremiumThe Fly
QuidelOrtho receives FDA 510k clearance for QuickVue COVID-19 test
1M ago
QuidelOrtho ‘vulnerable to an approach,’ says Gordon Haskett
PremiumThe FlyQuidelOrtho ‘vulnerable to an approach,’ says Gordon Haskett
3M ago
QuidelOrtho will postpone its previously announced Investor Day
PremiumThe Fly
QuidelOrtho will postpone its previously announced Investor Day
3M ago
QuidelOrtho Announces Executive Leadership Restructuring
PremiumCompany Announcements
QuidelOrtho Announces Executive Leadership Restructuring
3M ago
Airbnb downgraded, Citi upgraded: Wall Street’s top analyst calls
PremiumThe FlyAirbnb downgraded, Citi upgraded: Wall Street’s top analyst calls
3M ago
Craig-Hallum downgrades QuidelOrtho to Hold, cuts price target to $50
PremiumThe Fly
Craig-Hallum downgrades QuidelOrtho to Hold, cuts price target to $50
3M ago
QuidelOrtho price target lowered to $81 from $130 at RBC Capital
PremiumThe Fly
QuidelOrtho price target lowered to $81 from $130 at RBC Capital
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100